Medline Recalls Namic Angiographic Syringes Over Unwinding Risk
Summary
Medline Industries issued an urgent medical device recall for Namic Angiographic Rotating Adaptor (RA) Control Syringes and Convenience Kits after identifying that the syringe rotating adaptor may unwind during use, causing loose connections or full disconnection from the manifold. The FDA has classified this as the most serious recall type due to the risk of biohazard exposure, blood loss, infection, air embolism, serious injury, or death. Four serious injuries have been reported as of March 13.
What changed
Medline Industries, in coordination with the FDA, initiated a Class I recall of Namic Angiographic Rotating Adaptor (RA) Control Syringes and Convenience Kits containing RA Syringes. The recall was triggered by reports that the syringe rotating adaptor may unwind during use, resulting in loose connections or full disconnection between the syringe and manifold. The failure creates risks of biohazard exposure, blood loss, infection, air embolism, and death. All units are affected and four serious injuries have been reported. The recall notice was issued February 27 to affected customers with immediate quarantine and destruction instructions.
Healthcare facilities, distributors, and any entity using or reselling these syringes must immediately check stock for affected products, quarantine inventory, and destroy affected items after completing recall response forms. Over-labels must be applied to affected kits. In rare emergency situations where no alternative exists and postponement poses significant patient risk, the syringe may be used only with manual stabilization, continuous 100% monitoring, and strict adherence to usage guidelines.
What to do next
- Quarantine and destroy all affected Namic RA Syringes per recall response forms
- Apply over-labels to affected kits on hand stating affected syringes must be removed and discarded
- Notify downstream distributors or resellers of this recall communication
Archived snapshot
Apr 10, 2026GovPing captured this document from the original source. If the source has since changed or been removed, this is the text as it existed at that time.
This recall **involves removing devices from where they are used or sold.* The FDA has identified this recall as the most serious type. This device may cause serious injury or death if you continue to use it.*
Affected Product
The FDA is aware that Medline Industries has issued an Urgent Medical Device Recall to affected customers recommending all Namic Angiographic Rotating Adaptor (RA) Control Syringes and Convenience Kits containing RA Syringes be removed from where they are used or sold. Affected devices:
- Namic Angiographic Rotating Adaptor (RA) Control Syringes
- Convenience Kits containing Namic Angiographic Rotating Adaptor (RA) Control Syringes Full list of affected products.
What to Do
Remove and destroy all Namic RA Syringes. Apply over-labels to all affected kits on hand stating that the affected syringes must be removed and discarded from further use.
On February 27, Medline Industries sent all affected customers an Urgent Medical Device Recall notice recommending the following actions:
- Immediately check your stock for any affected product and quarantine. Destroy affected product after completing recall response forms.
- Apply provided over-labels to any affected kits on hand stating that the affected syringes must be removed and discarded from further use.
- If you are a distributor or have resold or transferred this product, notify them of this recall communication.
- In rare circumstances where angiography is urgently required, no alternative device is available, and postponing the procedure would place the patient at significant risk, the Namic RA syringe may be used with extreme caution and vigilance.
- Precautions include manual stabilization of syringe-to-manifold connections and continuous, 100% monitoring during setup and throughout the entire procedure. Strict adherence to all usage guidelines and the Instructions for Use is also required.
- If use is unavoidable, be prepared to follow the additional instructions provided in the Urgent Medical Device Recall notice if the syringe unwinds and causes a loose connection or disconnection during procedural setup or during the procedure.
Reason for Recall
Medline Industries stated that the syringe rotating adaptor on affected devices may unwind during use, resulting in a loose connection or full disconnection between the syringe and manifold. If unwinding occurs, there is potential for biohazard exposure, blood loss, and infection. Loose connections or disconnections may introduce air into the line, which could result in air embolism. These conditions may lead to serious injury or death. All units have the potential to exhibit this failure mode.
As of March 13, Medline Industries has reported four serious injuries and no deaths associated with this issue.
Device Use
The Namic Angiographic Control Syringe is intended to be used for the intra-arterial or intravenous administration of radiographic contrast media.
Contact Information
Customers in the U.S. with adverse reactions, quality problems, or questions about this issue should contact Medline Industries at recalls@medline.com or 866-359-1704.
Additional FDA Resources
Unique Device Identifier (UDI)
The unique device identifier (UDI) helps identify individual medical devices sold in the United States from distribution to use. The UDI allows for more accurate reporting, reviewing, and analyzing of adverse event reports so that devices can be identified more quickly, and as a result, problems potentially resolved more quickly.
- How do I recognize a UDI on a label?
- AccessGUDID database - Identify Your Medical Device
- Benefits of a UDI System
How do I report a problem?
Health care professionals and consumers may report adverse reactions or quality problems they experienced using these devices to MedWatch: The FDA Safety Information and Adverse Event Reporting Program.
- ## Content current as of:
04/09/2026
Regulated Product(s)
- Medical Devices
Named provisions
Related changes
Get daily alerts for FDA Medical Device Recalls
Daily digest delivered to your inbox.
Free. Unsubscribe anytime.
Source
About this page
Every important government, regulator, and court update from around the world. One place. Real-time. Free. Our mission
Source document text, dates, docket IDs, and authority are extracted directly from FDA.
The summary, classification, recommended actions, deadlines, and penalty information are AI-generated from the original text and may contain errors. Always verify against the source document.
Classification
Who this affects
Taxonomy
Browse Categories
Get alerts for this source
We'll email you when FDA Medical Device Recalls publishes new changes.
Subscribed!
Optional. Filters your digest to exactly the updates that matter to you.